To bypass the potential confounder of differences in antigen expression, we exogenously loaded one of two different peptides (CDK4R24C and NY-ESO-1) on melanoma cells, and subsequently co-cultured them with CD8+ T cells that had been transduced with their cognate TCRs. The gene discussed is CD8A; the disease is melanoma.